36358947 32256311 34077533 28764903 27110594 36085537 36160140 30048714 28353286 28353284 36063080 34360940 30876943 30872638 28679590 32247367 28202674 32765209 28668175 29177506 32916992 33779316 29258445 26906116 34425484 29460289 26811536 3155474 - Search Results

Year	Number of Results
2015	1
2016	3
2017	7
2018	4
2019	3
2020	4
2021	5
2022	4
2023	0

1

LRRK2 and Lipid Pathways: Implications for Parkinson's Disease.

Galper J, Kim WS, Dzamko N. Galper J, et al. Biomolecules. 2022 Oct 30;12(11):1597. doi: 10.3390/biom12111597. Biomolecules. 2022. PMID: 36358947 Free PMC article. Review.

2

The Emerging Functions of LRRK2 and Rab GTPases in the Endolysosomal System.

Kuwahara T, Iwatsubo T. Kuwahara T, et al. Front Neurosci. 2020 Mar 18;14:227. doi: 10.3389/fnins.2020.00227. eCollection 2020. Front Neurosci. 2020. PMID: 32256311 Free PMC article. Review.

3

BORCS6 is involved in the enlargement of lung lamellar bodies in Lrrk2 knockout mice.

Araki M, Ito K, Takatori S, Ito G, Tomita T. Araki M, et al. Hum Mol Genet. 2021 Aug 12;30(17):1618-1631. doi: 10.1093/hmg/ddab146. Hum Mol Genet. 2021. PMID: 34077533

4

Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease.

West AB. West AB. Exp Neurol. 2017 Dec;298(Pt B):236-245. doi: 10.1016/j.expneurol.2017.07.019. Epub 2017 Jul 29. Exp Neurol. 2017. PMID: 28764903 Free PMC article. Review.

5

Heme oxygenase-1 regulates mitochondrial quality control in the heart.

Hull TD, Boddu R, Guo L, Tisher CC, Traylor AM, Patel B, Joseph R, Prabhu SD, Suliman HB, Piantadosi CA, Agarwal A, George JF. Hull TD, et al. JCI Insight. 2016;1(2):e85817. doi: 10.1172/jci.insight.85817. JCI Insight. 2016. PMID: 27110594 Free PMC article.

6

Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.

Volta M. Volta M. Neurotherapeutics. 2022 Sep 9. doi: 10.1007/s13311-022-01290-z. Online ahead of print. Neurotherapeutics. 2022. PMID: 36085537 Review.

7

Functional consequence of myeloid ferritin heavy chain on acute and chronic effects of rhabdomyolysis-induced kidney injury.

McCullough KR, Akhter J, Taheri MJ, Traylor A, Zmijewska AA, Verma V, Hudson MC, Sachdeva A, Erman EN, Moore KH, George JF, Bolisetty S. McCullough KR, et al. Front Med (Lausanne). 2022 Sep 8;9:894521. doi: 10.3389/fmed.2022.894521. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36160140 Free PMC article.

8

The G2019S mutation in LRRK2 imparts resiliency to kinase inhibition.

Kelly K, Wang S, Boddu R, Liu Z, Moukha-Chafiq O, Augelli-Szafran C, West AB. Kelly K, et al. Exp Neurol. 2018 Nov;309:1-13. doi: 10.1016/j.expneurol.2018.07.012. Epub 2018 Jul 24. Exp Neurol. 2018. PMID: 30048714 Free PMC article.

9

Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.

Daher JP. Daher JP. Adv Neurobiol. 2017;14:209-226. doi: 10.1007/978-3-319-49969-7_11. Adv Neurobiol. 2017. PMID: 28353286 Review.

10

Models of LRRK2-Associated Parkinson's Disease.

Xiong Y, Dawson TM, Dawson VL. Xiong Y, et al. Adv Neurobiol. 2017;14:163-191. doi: 10.1007/978-3-319-49969-7_9. Adv Neurobiol. 2017. PMID: 28353284 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results